DiaMedica Therapeutics (DMAC) Institutional Ownership

$3.12
-0.13 (-4.00%)
(As of 05/10/2024 ET)

Institutional Ownership Changes (13F Filings) for DiaMedica Therapeutics (NASDAQ:DMAC)

Current
Institutional Ownership
Percentage
10.12%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$838.69K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$563.24K
Get DMAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DMAC Institutional Buying and Selling by Quarter

DiaMedica Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Vanguard Group Inc.1,013,522$2.81M0.0%+26.3%2.670%
2/15/2024Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318%
2/7/2024 Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033%
11/15/2023Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053%
11/13/2023EAM Investors LLC212,512$548K0.1%-21.4%0.560%
11/9/2023Bleichroeder LP222,317$574K0.1%-24.4%0.586%
11/1/2023Jacob Asset Management of New York LLC168,730$435K0.6%-15.1%0.445%
8/30/2023Cooperman Leon G875,993$3.78M0.2%+0.9%2.308%
8/10/2023Jacob Asset Management of New York LLC198,730$859K1.0%-15.0%0.738%
8/2/2023 Catalyst Financial Partners LLC36,267$157K0.1%+44.4%0.135%
4/11/2023 Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095%
5/12/2022Jacob Asset Management of New York LLC265,000$663K0.4%-3.6%1.002%
2/15/2022Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519%
11/15/2021Marshall Wace LLP10,031$40K0.0%-93.6%0.053%
11/15/2021Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454%
11/12/2021Stonepine Capital Management LLC165,775$665K0.3%-60.5%0.882%
11/12/2021Jump Financial LLC18,300$73K0.0%N/A0.097%
11/9/2021BlackRock Inc.55,970$225K0.0%-8.6%0.298%
8/25/2021Marshall Wace LLP155,662$693K0.0%+104.9%0.829%
8/16/2021State Street Corp30,217$134K0.0%N/A0.161%
8/16/2021Corriente Advisors LLC203,641$906K0.5%-76.6%1.084%
8/16/2021Marshall Wace LLP155,662$693K0.0%+104.9%0.829%
8/13/2021Renaissance Technologies LLC94,100$419K0.0%-38.5%0.501%
8/13/2021Geode Capital Management LLC133,569$594K0.0%+4.0%0.711%
8/13/2021Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185%
8/12/2021Trexquant Investment LP17,019$76K0.0%N/A0.091%
8/12/2021Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075%
8/12/2021JPMorgan Chase & Co.8,299$37K0.0%N/A0.044%
8/12/2021Bank of Montreal Can142,846$694K0.0%+36.7%0.760%
5/21/2021Citadel Advisors LLC20,601$189K0.0%N/A0.110%
5/19/2021Squarepoint Ops LLC35,536$325K0.0%N/A0.189%
5/18/2021Millennium Management LLC70,281$643K0.0%+72.0%0.374%
5/18/2021Point72 Asset Management L.P.552,250$5.05M0.0%-31.0%2.940%
5/18/2021Corriente Advisors LLC870,228$7.96M2.9%+7.8%4.632%
5/18/2021Citadel Advisors LLC20,601$189K0.0%N/A0.110%
5/13/2021Barclays PLC3,412$31K0.0%N/A0.018%
5/13/2021Renaissance Technologies LLC153,100$1.40M0.0%+35.0%0.815%
5/13/2021 Bank of New York Mellon Corp40,576$371K0.0%-5.4%0.216%
5/13/2021Bank of Montreal Can104,524$982K0.0%+27.7%0.556%
5/12/2021Northern Trust Corp85,026$778K0.0%-29.7%0.453%
The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
5/12/2021Geode Capital Management LLC128,468$1.18M0.0%+23.9%0.684%
5/12/2021Granite Point Capital Management L.P.184,380$1.69M0.1%-66.3%0.981%
5/11/2021EAM Investors LLC108,232$990K0.1%-1.6%0.576%
5/7/2021BlackRock Inc.60,165$551K0.0%+7.9%0.320%
4/27/2021 Dorsey Wright & Associates3,937$36K0.4%N/A0.021%
2/24/2021Virtu Financial LLC15,712$159K0.0%N/A0.084%
2/17/2021Jane Street Group LLC12,537$127K0.0%N/A0.067%
2/16/2021ExodusPoint Capital Management LP13,160$133K0.0%N/A0.070%
2/12/2021Stonepine Capital Management LLC950,000$9.63M7.4%-17.1%5.070%
2/11/2021Northern Trust Corp120,989$1.23M0.0%+3.6%0.646%
2/11/2021 Valeo Financial Advisors LLC5,000$51K0.0%N/A0.027%
2/10/2021Renaissance Technologies LLC113,400$1.15M0.0%+18.1%0.605%
2/9/2021 Bank of New York Mellon Corp42,905$435K0.0%+218.5%0.229%
2/6/2021Granite Point Capital Management L.P.546,855$5.55M0.3%-15.5%2.918%
2/5/2021BlackRock Inc.55,781$566K0.0%+27.4%0.298%
11/17/2020Nantahala Capital Management LLC756,193$3.21M0.1%+0.8%4.035%
11/16/2020Point72 Asset Management L.P.800,000$3.39M0.0%N/A4.269%
11/16/2020Worth Venture Partners LLC42,887$182K0.1%N/A0.229%
11/16/2020Manatuck Hill Partners LLC571,500$2.42M1.1%+62.8%3.050%
11/16/2020Boothbay Fund Management LLC46,562$197K0.0%N/A0.248%
11/13/2020Stonepine Capital Management LLC1,146,470$4.86M5.1%+71.5%6.118%
11/13/2020Morgan Stanley9,100$38K0.0%+56.9%0.049%
11/6/2020Granite Point Capital Management L.P.646,855$2.74M0.1%+35.5%3.452%
11/3/2020Corriente Advisors LLC730,000$3.10M1.6%+262.7%3.895%
8/14/2020Corriente Advisors LLC201,248$1.40M0.9%N/A1.423%
8/12/2020 Bank of New York Mellon Corp13,472$93K0.0%N/A0.095%
5/14/2020Stonepine Capital Management LLC825,297$2.31M2.4%N/A5.837%
5/1/2020BlackRock Inc.38,373$108K0.0%+19.7%0.271%
(Data available from 1/1/2016 forward)

DMAC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DMAC shares?

During the previous two years, 9 institutional investors and hedge funds held shares of DiaMedica Therapeutics. The most heavily invested institutionals were Cooperman Leon G ($3.78M), Vanguard Group Inc. ($2.81M), Paragon Associates & Paragon Associates II Joint Venture ($1.42M), Bleichroeder LP ($574K), EAM Investors LLC ($548K), Jacob Asset Management of New York LLC ($435K), and Catalyst Financial Partners LLC ($157K).Learn more on DMAC's institutional investors.

What percentage of DiaMedica Therapeutics stock is owned by institutional investors?

10.12% of DiaMedica Therapeutics stock is owned by institutional investors. Learn more on DMAC's institutional investor holdings.

Which institutional investors have been buying DiaMedica Therapeutics stock?

The following institutional investors have purchased DiaMedica Therapeutics stock in the last 24 months: Vanguard Group Inc. ($211.35K), Paragon Associates & Paragon Associates II Joint Venture ($30K), Catalyst Financial Partners LLC ($21.79K), Stonebridge Capital Advisors LLC ($20K), Avantax Advisory Services Inc. ($12.50K), and Cooperman Leon G ($7.58K).

How much institutional buying is happening at DiaMedica Therapeutics?

Institutional investors have bought a total of 303,223 shares in the last 24 months. This purchase volume represents approximately $870.91K in transactions.

Which DiaMedica Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold DiaMedica Therapeutics stock in the last 24 months: Jacob Asset Management of New York LLC ($75K), Bleichroeder LP ($71.80K), and EAM Investors LLC ($57.91K).

How much institutional selling is happening at DiaMedica Therapeutics?

Institutional investors have sold a total of 204,707 shares in the last 24 months. This volume of shares sold represents approximately $613.64K in transactions.


This page (NASDAQ:DMAC) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners